Brief: GoodRx Holdings Q4 Adjusted Net Income USD 31.1 Million Vs. IBES Estimate USD 27.1 Million
29/02/2024 11:02
Feb 29 (Reuters) - GoodRx Holdings Q4 revenue USD 196.6 million vs. IBES estimate USD 195.8 million. * Q4 net income USD -25.9 million * Q4 adjusted EBITDA margin 29.1% * Q4 adjusted EBITDA USD 57.3 million vs. IBES estimate USD 54.6 million
Recent news on GoodRx Holdings
See all newsAmazon, GoodRx target US prescription subscribers as health insurance coverage slips
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
GoodRx Q2 revenue beats estimates; raises 2026 outlook
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million